Early diagnosis and predictive model for hepatitis B virus-related hepatocellular carcinoma
10.3760/cma.j.cn501113-20190201-00042
- VernacularTitle:乙型肝炎病毒相关性肝癌的早期诊断与预测模型
- Author:
Shitian YANG
1
;
Wei WANG
;
Yadong WANG
;
Caiyan ZHAO
Author Information
1. 陆军军医大学士官学校战救医疗系，石家庄 050081
- Keywords:
Liver cell carcinoma;
Hepatitis B;
Forecasting model;
Antiviral therapy
- From:
Chinese Journal of Hepatology
2022;30(6):667-671
- CountryChina
- Language:Chinese
-
Abstract:
Most hepatocellular carcinoma are diagnosed at an advanced stage and thereby have a high mortality rate. Thus, the key to improving patient prognosis is early diagnosis of hepatocellular carcinoma. In recent years, Asian scholars have summarized a series of hepatocellular carcinoma risk score model for population with chronic hepatitis B, which can help to identify high-risk groups early and improve the early diagnosis rate. This paper briefly analyzes the risk factors and validated risk model for early prediction of hepatitis B virus-related hepatocellular carcinoma, and further reviews the effect of antiviral therapy on the risk of hepatocellular carcinoma.
